Recruiting
Phase 1

Sponsor:

K36 Therapeutics, Inc.

Code:

NCT05651932

Conditions

Multiple Myeloma

Myeloma

Myeloma Multiple

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cohort A1 & A2

Cohort C1 & C2

Cohort D

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by K36 Therapeutics, Inc. on 2024-12-16.